Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Genetron Holdings Ltd is a diagnostics & research business based in the US. Genetron shares (GTH) are listed on the NASDAQ and all prices are listed in US Dollars. Genetron employs 1,154 staff and has a trailing 12-month revenue of around $550.2 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $0.78 |
|---|---|
| 52-week range | $0.80 - $14.60 |
| 50-day moving average | $1.08 |
| 200-day moving average | $2.55 |
| Wall St. target price | $3.72 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.90 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.782 from 2022-09-30
| 1 week (2022-09-23) | -14.25% |
|---|---|
| 1 month (2022-09-02) | -30.80% |
| 3 months (2022-07-01) | -53.45% |
| 6 months (2022-04-01) | -67.42% |
| 1 year (2021-10-01) | -94.30% |
|---|---|
| 2 years (2020-10-02) | -93.48% |
| 3 years (2019-09-28) | N/A |
| 5 years (2017-09-28) | N/A |
| Revenue TTM | $550.2 million |
|---|---|
| Gross profit TTM | $338 million |
| Return on assets TTM | -23.13% |
| Return on equity TTM | -42.57% |
| Profit margin | -101.39% |
| Book value | $11.19 |
| Market capitalisation | $73.4 million |
TTM: trailing 12 months
We're not expecting Genetron to pay a dividend over the next 12 months.
Over the last 12 months, Genetron's shares have ranged in value from as little as $0.8 up to $14.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genetron's is 0.0055. This would suggest that Genetron's shares are less volatile than average (for this exchange).
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.